Search Within

Parastoo Bahrami Dahi

  1. "Dermatology Service"
Formats
  1. Meeting Abstract (5)
Groups
  1. Bone Marrow Transplant (5)
  2. CTCR Scholars (5)
  3. Center for Hematologic Malignancies (5)
  4. Department of Medicine (5)
  5. Dermatology (5)
  6. Dermatology Service (5)

More Groups

People
  1. Alina Markova (3)
  2. Craig Sauter (3)
  3. Doris Ponce (3)
  4. Melissa Pulitzer (3)
  5. Ahmet Dogan (2)
  6. Ai Ni (2)

More People

Years
  1. 2022 (1)
  2. 2019 (1)
  3. 2018 (1)
  4. 2017 (1)
  5. 2016 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (2)
  2. Blood (2)
  3. Transplantation and Cellular Therapy (1)
Publishers
  1. Elsevier Inc. (3)
  2. American Society of Hematology (2)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peri-transplant vitamin and micronutrient status in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rodich, L.; Adintori, P. A.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Gossman, Z.; Shike, M.; Barker, J. N.; Jakubowski, A. A.; Kernan, N. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Photobiomodulation (PBM) provides a prompt and near-resolution response to advanced oral chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
    Meeting Abstract

    Ponce, D. M.; Markova, A.; Moore, G.; Dahi, P. B.; Papadopoulos, E. B.; Tamari, R.; Giralt, S. A.; Prockop, S. E.; Barash, A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • De novo skin xerosis in cord blood transplantation is associated with distinct histopathology and treatment response: First literature report of cord dermatosis
    Meeting Abstract

    Markova, A.; Pulitzer, M.; Jain, M.; Dierov, D.; Dahi, P. B.; Gyurkocza, B.; Sauter, C. S.; Spitzer, B.; Barker, J. N.; Ponce, D. M.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save